Daniel Ejim Uti
Impact in
-
- Curcumin's Biomedical Applications
Papers in
-
- Natural Antidiabetic Agents Studies 11
- Diet, Metabolism, and Disease 4
-
- Extracellular vesicles in disease 3
- RNA Interference and Gene Delivery 2
- Co-authors
- Esther Ugo Alum (28 shared papers)Item Justin Atangwho (15 shared papers)Okechukwu Paul-Chima Ugwu (9 shared papers)Godwin Eneji Egbung (6 shared papers)Simeon Ikechukwu Egba (6 shared papers)Mariam Basajja (5 shared papers)Swastika Maitra (7 shared papers)Regina Idu Ejemot-Nwadiaro (5 shared papers)
In The Last Decade
Daniel Ejim Uti
48 papers receiving 424 citations
Daniel Ejim Uti's Hit Papers
Peers
Comparison fields: 5 of 94
- Complementary and alternative medicine 38
- Molecular Medicine 23
- Pharmacology 39
- Biochemistry 24
- Endocrinology, Diabetes and Metabolism 61
Countries citing papers authored by Daniel Ejim Uti
This map shows the geographic impact of Daniel Ejim Uti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ejim Uti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ejim Uti more than expected).
Fields of papers citing papers by Daniel Ejim Uti
This network shows the impact of papers produced by Daniel Ejim Uti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ejim Uti. The network helps show where Daniel Ejim Uti may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Ejim Uti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 65 | |
| 2 | Sustainable development goals (SDGs) and resilient healthcare systems: Addressing medicine and public health challenges in conflict zones Hit paper breakdown → | 2025 | 55 |
| 3 | 2023 | 37 | |
| 4 | Cytokines as key players in obesity low grade inflammation and related complications Hit paper breakdown → | 2025 | 33 |
| 5 | 2024 | 32 | |
| 6 | 2012 | 28 | |
| 7 | 2025 | 23 | |
| 8 | 2025 | 20 | |
| 9 | 2025 | 18 | |
| 10 | 2023 | 17 | |
| 11 | 2019 | 17 | |
| 12 | 2025 | 15 | |
| 13 | 2022 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2024 | 11 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2025 | 9 | |
| 19 | 2024 | 7 | |
| 20 | 2024 | 7 |
About Daniel Ejim Uti
Daniel Ejim Uti is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cancer Research, Pharmacology and Complementary and alternative medicine, having authored 56 papers that have together received 504 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (11 papers), Diet, Metabolism, and Disease (4 papers), Cholesterol and Lipid Metabolism (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Nanoparticles: synthesis and applications (3 papers), Extracellular vesicles in disease (3 papers), Drug Solubulity and Delivery Systems (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Complementary and alternative medicine (38 citations), Molecular Medicine (23 citations), Pharmacology (39 citations), Biochemistry (24 citations) and Endocrinology, Diabetes and Metabolism (61 citations). Daniel Ejim Uti has collaborated with scholars based in Nigeria, Uganda and India. Frequent co-authors include Esther Ugo Alum, Item Justin Atangwho, Okechukwu Paul-Chima Ugwu, Godwin Eneji Egbung, Simeon Ikechukwu Egba, Mariam Basajja, Swastika Maitra, Regina Idu Ejemot-Nwadiaro, Mohamed M. Abdel‐Daim and Popat Mohite. Their work appears in journals such as Natural Product Communications, Scientific Reports, Medicine, Journal of Cellular and Molecular Medicine and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.